18 days ago
JAZZ
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +972.34% | $28.60 | $306.69 | 2025-04-08 - 2026-04-07 | Buy |
Praxis Precision Medicines IncPRAX | +885.37% | $33.55 | $330.59 | 2025-03-03 - 2026-03-02 | Buy |
Praxis Precision Medicines IncPRAX | +766.56% | $38.96 | $337.61 | 2025-05-05 - 2026-05-04 | Buy |
Revolution Medicines IncRVMD | +465.98% | $34.95 | $197.81 | 2025-08-07 - 2026-08-06 | Buy |
Praxis Precision Medicines IncPRAX | +450.70% | $45.03 | $247.98 | 2025-06-12 - 2026-06-11 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Maplight Therapeutics IncMPLT | 4 | Buy | $43.00 | +230.77% | Maintains | 13 days ago |
Revolution Medicines IncRVMD | 34 | Buy | $275.00 | +34.96% | Maintains | 13 days ago |
Jazz Pharmaceuticals PLCJAZZ | 36 | Buy | $310.00 | +26.12% | Maintains | 18 days ago |
Definium Therapeutics IncDFTX | 3 | Buy | $66.00 | +69.71% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 13 | Buy | $41.00 | +47.32% | Maintains | a month ago |
Axsome Therapeutics IncAXSM | 21 | Buy | $268.00 | +21.40% | Maintains | a month ago |
Praxis Precision Medicines IncPRAX | 20 | Buy | $582.00 | +73.95% | Maintains | a month ago |
Gh Research PLCGHRS | 5 | Buy | $39.00 | +43.38% | Maintains | a month ago |
Harmony Biosciences Holdings IncHRMY | 41 | Buy | $50.00 | +20.42% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 19 | Buy | $204.00 | +30.59% | Maintains | a month ago |
Bicycle Therapeutics PLCBCYC | 23 | Buy | $14.00 | +262.69% | Maintains | a month ago |
Immuneering CorpIMRX | 22 | Buy | $18.00 | +321.55% | Maintains | 2 months ago |
Ataibeckley IncATAI | 3 | Hold | N/A | N/A | Downgrades | 2 months ago |
Alkermes PLCALKS | 8 | Buy | $62.00 | +34.87% | Maintains | 2 months ago |
Biogen IncBIIB | 45 | Buy | $256.00 | +17.89% | Maintains | 2 months ago |
Neumora Therapeutics IncNMRA | 12 | Buy | $5.00 | +380.77% | Maintains | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Hold | N/A | N/A | Downgrades | 5 months ago |
Day One Biopharmaceuticals IncDAWN | 24 | Hold | N/A | N/A | Downgrades | 6 months ago |
Cogent Biosciences IncCOGT | 24 | Hold | N/A | N/A | Reiterates | 9 months ago |
Avadel Pharmaceuticals PLCAVDL | 36 | Hold | N/A | N/A | Downgrades | a year ago |
Merus NvMRUS | 31 | Hold | $96.00 | +6.67% | Downgrades | a year ago |
Sage Therapeutics IncSAGE | 22 | Hold | N/A | N/A | Reiterates | a year ago |
Blueprint Medicines CorpBPMC | 31 | Hold | $130.00 | N/A | Downgrades | a year ago |
Intra Cellular Therapies IncITCI | 27 | Hold | N/A | N/A | Reiterates | 2 years ago |
Theseus Pharmaceuticals IncTHRX | 6 | Hold | N/A | N/A | Downgrades | 3 years ago |
Seagen IncSGEN | 7 | Hold | N/A | N/A | Downgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Amryt Pharma PLCAMYT | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $26.00 | N/A | Maintains | 6 years ago |
Amarin Corp PLCAMRN | 2 | Buy | $320.00 | N/A | Maintains | 6 years ago |
Pacira Biosciences IncPCRX | 3 | Hold | $75.00 | N/A | Downgrades | 6 years ago |
Obseva SaOBSVF | 1 | Buy | $5.00 | N/A | Maintains | 6 years ago |
Amag Pharmaceuticals IncAMAG | 1 | Hold | $13.65 | N/A | Maintains | 6 years ago |
Iterum Therapeutics PLCITRMF | 4 | Hold | $22.50 | N/A | Maintains | 6 years ago |
Perrigo Co PLCPRGO | 3 | Buy | $63.00 | N/A | Maintains | 6 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 7 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Endo International PLCENDPQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 9 years ago |
Heron Therapeutics IncHRTX | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 9 years ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Strong Sell | $13.00 | N/A | Initiates Coverage On | 9 years ago |